Connect your AI

Absci Corporation ABSI Short- term Investments

Short- term Investments at other companies

SchrodingerSDGR

——

Apogee Therapeutics, Inc.APGE

——

Other financials

Income statement

Revenue$215.0K-81.8%

Operating income-$30.8M-11.2%

Net income-$29.6M-12.3%

EPS (diluted)-$0.19+9.5%

Balance sheet

Cash & equivalents$9.7M-84.9%

Total debt$4.0M-37.2%

Total equity$172.0M-13.5%

Total assets$195.6M-15.9%

Cash flow

Operating cash flow-$26.3M-20.5%

CapEx$30.0K+20.0%

Free cash flow-$26.3M-20.5%

Valuation

Market cap$1.57B+341%

Enterprise value$1.57B+425%

P/S855.5×+782×

Profitability

Operating margin-6,723%-14,525pp

Net margin-6,450.8%-13,699pp

FCF margin-5,365.2%-9,300pp

Returns & leverage

Return on equity-63.9%+28.0pp

Debt / equity0×0.0×

Current ratio6.6×+0.9×

Where this comes from

Reported directly by Absci Corporation in its filing.

Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.

The official record: Absci Corporation’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Absci Corporation's short- term investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Absci Corporation's short- term investments?: Absci Corporation (ABSI) reported short- term investments of $117.08M in Q1 2026.